1,058
Views
4
CrossRef citations to date
0
Altmetric
LETTER TO THE EDITOR: MEDICAL ONCOLOGY

Analysis of human papillomaviruses and human polyomaviruses in lung cancer from Swedish never-smokers

ORCID Icon, , , , , , , , ORCID Icon, ORCID Icon, ORCID Icon, & show all
Pages 28-32 | Received 21 May 2019, Accepted 15 Aug 2019, Published online: 28 Aug 2019

References

  • Torre LA, Bray F, Siegel RL, et al. Global cancer statistics, 2012. CA Cancer J Clin. 2015;65:87–108.
  • D'Addario G, Felip E, Group EGW. Non-small-cell lung cancer: ESMO clinical recommendations for diagnosis, treatment and follow-up. Ann Oncol. 2009;20:68–70.
  • Sun S, Schiller JH, Gazdar AF. Lung cancer in never smokers—a different disease. Nat Rev Cancer. 2007;7:778–790.
  • Pelosof L, Ahn C, Gao A, et al. Proportion of never-smoker non-small cell lung cancer patients at three diverse institutions. J Natl Cancer Inst. 2017;109:djw295.
  • Welfare TNBoHa. Nationellt lungcancerregister (National Lung Cancer Registry) [Internet]; Stockholm: National Board of Health and Welfare; 2016. Available from: http://www.socialstyrelsen.se/register/registerservice/nationellakvalitetsregister/nationelltlungcancerregister
  • Choi JR, Park SY, Noh OK, et al. Gene mutation discovery research of non-smoking lung cancer patients due to indoor radon exposure. Ann Occup Environ Med. 2016;28:13.
  • Hamra GB, Guha N, Cohen A, et al. Outdoor particulate matter exposure and lung cancer: a systematic review and meta-analysis. Environ Health Perspect. 2014;122:906–911.
  • Taylor R, Najafi F, Dobson A. Meta-analysis of studies of passive smoking and lung cancer: effects of study type and continent. Int J Epidemiol. 2007;36:1048–1059.
  • Khoury JD, Tannir NM, Williams MD, et al. Landscape of DNA virus associations across human malignant cancers: analysis of 3,775 cases using RNA-Seq. J Virol. 2013;87:8916–8926.
  • Tang KW, Alaei-Mahabadi B, Samuelsson T, et al. The landscape of viral expression and host gene fusion and adaptation in human cancer. Nat Commun. 2013;4:2513.
  • Syrjanen K. Detection of human papillomavirus in lung cancer: systematic review and meta-analysis. Anticancer Res. 2012;32:3235–3250.
  • Ragin C, Obikoya-Malomo M, Kim S, et al. HPV-associated lung cancers: an international pooled analysis. Carcinogenesis. 2014;35:1267–1275.
  • Koshiol J, Rotunno M, Gillison ML, et al. Assessment of human papillomavirus in lung tumor tissue. J Natl Cancer Inst. 2011;103:501–507.
  • Hasegawa Y, Ando M, Kubo A, et al. Human papilloma virus in non-small cell lung cancer in never smokers: a systematic review of the literature. Lung Cancer. 2014;83:8–13.
  • Joh J, Jenson AB, Moore GD, et al. Human papillomavirus (HPV) and Merkel cell polyomavirus (MCPyV) in non small cell lung cancer. Exp Mol Pathol. 2010;89:222–226.
  • Behdarvand A, Zamani MS, Sadeghi F, et al. Evaluation of Merkel cell polyomavirus in non-small cell lung cancer and adjacent normal cells. Microb Pathog. 2017;108:21–26.
  • Giuliani L, Jaxmar T, Casadio C, et al. Detection of oncogenic viruses SV40, BKV, JCV, HCMV, HPV and p53 codon 72 polymorphism in lung carcinoma. Lung Cancer. 2007;57:273–281.
  • Csoma E, Bidiga L, Mehes G, et al. Survey of KI, WU, MW, and STL polyomavirus in cancerous and non-cancerous lung tissues. Pathobiology. 2018;85:179–185.
  • Zheng H, Abdel Aziz HO, Nakanishi Y, et al. Oncogenic role of JC virus in lung cancer. J Pathol. 2007;212:306–315.
  • IARC. Human papillomaviruses. IARC monographs on the evaluation of carcinogenic risk to humans. A review of human carcinogens. B. Biological agents. Vol. 100B. Lyon (France): WHO; 2011. p. 261–301.
  • Ramqvist T, Dalianis T. Oropharyngeal cancer epidemic and human papillomavirus. Emerg Infect Dis. 2010;16:1671–1677.
  • Haeggblom L, Ramqvist T, Tommasino M, et al. Time to change perspectives on HPV in oropharyngeal cancer. A systematic review of HPV prevalence per oropharyngeal sub-site the last 3 years. Papillomavirus Res. 2017;4:1–11.
  • Feng H, Shuda M, Chang Y, et al. Clonal integration of a polyomavirus in human Merkel cell carcinoma. Science. 2008;319:1096–1100.
  • Ramqvist T, Dalianis T. Lessons from immune responses and vaccines against murine polyomavirus infection and polyomavirus-induced tumours potentially useful for studies on human polyomaviruses. Anticancer Res. 2010;30:279–284.
  • Brostoff T, Dela Cruz FN, Jr., Church ME, et al. The Raccoon polyomavirus genome and tumor antigen transcription are stable and abundant in neuroglial tumors. J Virol. 2014;88:12816–12824.
  • van der Meijden E, Janssens RW, Lauber C, et al. Discovery of a new human polyomavirus associated with trichodysplasia spinulosa in an immunocompromised patient. PLoS Pathog. 2010;6:e1001024.
  • Dalianis T, Hirsch HH. Human polyomaviruses in disease and cancer. Virology. 2013;437:63–72.
  • Gheit T, Munoz JP, Levican J, et al. Merkel cell polyomavirus in non-small cell lung carcinomas from Chile. Exp Mol Pathol. 2012;93:162–166.
  • Teramoto S, Kaiho M, Takano Y, et al. Detection of KI polyomavirus and WU polyomavirus DNA by real-time polymerase chain reaction in nasopharyngeal swabs and in normal lung and lung adenocarcinoma tissues. Microbiol Immunol. 2011;55:525–530.
  • Dalianis T, Grun N, Koch J, et al. Human papillomavirus DNA and p16(INK4a) expression in hypopharyngeal cancer and in relation to clinical outcome, in Stockholm, Sweden. Oral Oncol. 2015;51:857–861.
  • Ramqvist T, Nordfors C, Dalianis T, et al. DNA from human polyomaviruses, TSPyV, MWPyV, HPyV6, 7 and 9 was not detected in primary mucosal melanomas. Anticancer Res. 2014;34:639–643.
  • Gustafsson B, Priftakis P, Rubin J, et al. Human polyomaviruses were not detected in cerebrospinal fluid of patients with neurological complications after hematopoietic stem cell transplantation. Future Virol. 2013;8:809–814.
  • Franzen J, Ramqvist T, Bogdanovic G, et al. Studies of human polyomaviruses, with HPyV7, BKPyV, and JCPyV present in urine of allogeneic hematopoietic stem cell transplanted patients with or without hemorrhagic cystitis. Transpl Infect Dis. 2016;18:240–246.
  • Foulongne V, Courgnaud V, Champeau W, et al. Detection of Merkel cell polyomavirus on environmental surfaces. J Med Virol. 2011;83:1435–1439.
  • Cheng YW, Chiou HL, Sheu GT, et al. The association of human papillomavirus 16/18 infection with lung cancer among nonsmoking Taiwanese women. Cancer Res. 2001;61:2799–2803.
  • Bae JM, Kim EH. Human papillomavirus infection and risk of lung cancer in never-smokers and women: an 'adaptive' meta-analysis. Epidemiol Health. 2015;37:e2015052.
  • Li YJ, Tsai YC, Chen YC, et al. Human papilloma virus and female lung adenocarcinoma. Semin Oncol. 2009;36:542–552.
  • Wu MF, Cheng YW, Lai JC, et al. Frequent p16INK4a promoter hypermethylation in human papillomavirus-infected female lung cancer in Taiwan. Int J Cancer. 2005;113:440–445.
  • Wang Y, Wang A, Jiang R, et al. Human papillomavirus type 16 and 18 infection is associated with lung cancer patients from the central part of China. Oncol Rep. 2008;20:333–339.
  • Sagerup CM, Nymoen DA, Halvorsen AR, et al. Human papilloma virus detection and typing in 334 lung cancer patients. Acta Oncol. 2014;53:952–957.
  • Colombara DV, Manhart LE, Carter JJ, et al. Absence of an association of human polyomavirus and papillomavirus infection with lung cancer in China: a nested case-control study. BMC Cancer. 2016;16:342.
  • Liang H, Pan Z, Cai X, et al. The association between human papillomavirus presence and epidermal growth factor receptor mutations in Asian patients with non-small cell lung cancer. Transl Lung Cancer Res. 2018;7:397–403.
  • Kim GJ, Lee JH, Lee DH. Clinical and prognostic significance of Merkel cell polyomavirus in nonsmall cell lung cancer. Medicine (Baltimore). 2017;96:e5413.
  • Babakir-Mina M, Ciccozzi M, Campitelli L, et al. Identification of the novel KI polyomavirus in paranasal and lung tissues. J Med Virol. 2009;81:558–561.
  • Toptan T, Yousem SA, Ho J, et al. Survey for human polyomaviruses in cancer. JCI Insight. 2016;1.
  • Malhotra J, Waterboer T, Pawlita M, et al. Serum biomarkers of polyomavirus infection and risk of lung cancer in never smokers. Br J Cancer. 2016;115:1131–1139.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.